This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: University of Georgia Research Foundation Inc. Active years: 2011-2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2011-2013
Title: The Innovations of Anthony C Capomacchia
Introduction
Anthony C Capomacchia is a notable inventor based in Bishop, GA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of glucosamine-based treatments. With a total of 2 patents to his name, Capomacchia's work focuses on innovative compositions and methods for treating various disorders.
Latest Patents
Capomacchia's latest patents include groundbreaking work on glucosamine and glucosamine/anti-inflammatory mutual prodrugs. These patents detail compositions and methods for administering glucosamine and its derivatives, aimed at treating disorders and conditions effectively. The topical compositions he has developed also utilize glucosamine and its analogs, showcasing his commitment to advancing therapeutic options in the pharmaceutical industry.
Career Highlights
Capomacchia is affiliated with the University of Georgia Research Foundation, Inc., where he continues to push the boundaries of research and innovation. His work has garnered attention for its potential impact on health and wellness, particularly in the realm of anti-inflammatory treatments.
Collaborations
Throughout his career, Capomacchia has collaborated with esteemed colleagues such as Solomon T Garner, Jr. and J Warren Beach. These partnerships have further enriched his research and contributed to the success of his innovative projects.
Conclusion
Anthony C Capomacchia stands out as a dedicated inventor whose work in glucosamine-based therapies has the potential to transform treatment options for various health conditions. His contributions to the field are noteworthy and reflect a commitment to innovation and excellence.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile